Senior international pharma leader, visionary and passionate for creating and delivering sustainable solutions to answer patient needs. I achieve results through talent management, building and leading world-class teams in a global setting.
With nearly 25 years-experience in pharma industry with Novo Nordisk, LEO Pharma, Eli Lilly, Santaris Pharma and latest Zealand Pharma in different roles, different functional and therapy areas (diabetes, bleeding disorders, intensive care, cancer and dermatology), I have built competencies in drug and device development and commercialization. My core expertise is within drug safety/pharmacovigilance, medical science and medical communication, regulatory processes (dossier/label negotiations with major regulatory authorities) and clinical quality assurance.